我国加入WTO已是大势所趋，届时，中小型制药企业的生存空间将发生重大变化，既要继续面对国内大企业的竞争，又要迎接来自国外大企业、大集团的竞争挑战。国有中小型制药企业如何在来自国内外医企竞争的夹缝中生存发展？笔者认为，抢抓机遇，深化改革，调整战略，强化管理从以 China’s accession to the WTO is a general trend. By then, the small and medium-sized pharmaceutical companies will experience major changes in their living space. They will not only continue to face the competition of large domestic companies, but also meet the challenges of competition from large foreign companies and large groups. How can state-owned small and medium-sized pharmaceutical companies survive and develop in the cracks of competition from domestic and foreign companies? The author believes that seizing opportunities, deepening reforms, adjusting strategies, and strengthening management from